Best Supplements for Neuropathy, Ranked by Clinical Evidence

10 supplements · 6 outcomes · 16 trials

Our #1 pick

Alpha-Lipoic Acid Likely helps Good · 53

The most-studied neuropathy supplement, with real but modest results

600 mg daily. Some trials tested 1200-1800 mg, but higher doses caused more GI side effects without clear additional benefit.

Symptom improvement in trials typically appeared by 3 to 5 months. The 4-year NATHAN-1 trial showed impairment scores improving gradually over years.

Peripheral neuropathy is a frustrating condition to treat because the damage is structural, not just inflammatory. Nerves that have been corroded by years of high blood sugar, crushed by repetitive motion, or poisoned by chemotherapy don't bounce back easily. That's reflected in the research: most supplements tested for neuropathy show modest effects at best, and the strongest evidence comes with important caveats.

What follows is an honest ranking. Alpha-lipoic acid leads because it has the most clinical data, but even a Cochrane review concluded the benefits are uncertain. Vitamin B12 works well for a specific subset of people. And PEA is a newcomer with genuinely interesting pain data, though the trials are small. If you're looking for a miracle supplement for neuropathy, it doesn't exist yet. But there are a few reasonable options worth understanding.

#1 deep dive

Why Alpha-Lipoic Acid takes the top spot

How it works

Alpha-lipoic acid is a potent antioxidant that works in both water and fat, giving it access to nerve tissue that most antioxidants can't reach. In diabetic neuropathy, chronic high blood sugar generates oxidative stress that damages nerve fibers. ALA helps neutralize that damage and may improve blood flow to peripheral nerves.⁶¹

What the research says

The evidence is deeper than for any other neuropathy supplement, but it's also more complicated than supplement marketers suggest. A 2024 Cochrane review pooling three long-term trials found that ALA 'probably has little or no effect' on neuropathy symptoms at six months.⁵ However, a separate 2023 meta-analysis of shorter trials showed meaningful improvement in symptom scores and neurological disability, with patients more likely to report satisfaction at 600 mg daily.³ The landmark NATHAN-1 trial followed 460 people for four years and found that while ALA missed its primary composite endpoint, individual measures of nerve impairment and muscle weakness did improve.⁶ The pattern suggests ALA may help with symptom burden more than it reverses underlying nerve damage, and the benefits take time to show.

Best for

People with diabetic peripheral neuropathy who are already managing their blood sugar. The vast majority of ALA neuropathy research is in this population. There is little evidence it helps chemotherapy-induced neuropathy.⁷

Watch out

ALA can lower blood sugar, which matters if you're on insulin or sulfonylureas. Rare cases of insulin autoimmune syndrome have been reported. GI upset (nausea, diarrhea) is the most common complaint, especially above 600 mg.

Pro tip

Take ALA on an empty stomach. Food significantly reduces absorption. The R-enantiomer (R-ALA) is the biologically active form, though most trials used racemic ALA.

Evidence by outcome

Ease diabetic nerve symptoms Likely helps

Improves weakness, sensation, and overall nerve symptom scores in diabetes.

d=0.98 Moderate effect 11 endpoints trust 71

Improve nerve signals in neuropathy Likely helps

Helps damaged nerves carry signals faster and more strongly.

d=1.42 Large effect 6 endpoints trust 53

Ease nerve pain symptoms Early data

Studies tracked burning, discomfort, and other nerve-related pain sensations.

d=0.46 Small effect 5 endpoints trust 27

Expected: ↓1.7 on NRS (meaningful at 2) · 9 weeks

Ease neuropathy symptoms Early data

Reduces numbness, tingling, weakness, and other nerve-related complaints.

d=0.09 Minimal effect 6 endpoints trust 19

Reduce nerve damage from chemotherapy Not enough research

Tracks neuropathy symptoms and neurotoxicity caused by cancer treatment.

d=0.01 Minimal effect 1 endpoints trust 12

Vitamin B12 (Methylcobalamin)

Likely helps

Strong · 66 Minimal effect

The right fix for the right problem: deficiency-driven nerve damage

1000 mcg (1 mg) methylcobalamin daily. The key neuropathy trial used this dose for 12 months.

Blood levels normalize within weeks, but nerve improvements took 6 to 12 months in the longest trial.

Full breakdown

How it works

B12 is essential for maintaining the myelin sheath that insulates nerve fibers. When B12 drops too low, myelin breaks down and nerve signals slow or misfire. Metformin, the most commonly prescribed diabetes drug, depletes B12 over time, creating a situation where diabetic neuropathy and B12-deficiency neuropathy compound each other.⁹⁸

What the research says

A well-designed 12-month RCT of 90 diabetic patients on long-term metformin with low B12 found that 1000 mcg daily methylcobalamin improved multiple nerve conduction measures, pain scores, foot sweat function, and symptom questionnaires compared to placebo.⁸ That's a clear win for a specific population. But a larger trial of 209 older adults with moderate B12 deficiency (but without diabetes) found zero benefit on any nerve conduction or cognitive measure after 12 months of supplementation.⁹ The difference is telling: B12 helps when deficiency is actively causing nerve damage, not as a general neuropathy treatment.

Best for

Diabetics on metformin, anyone with confirmed low B12 levels, and people on proton pump inhibitors or with absorption issues. Get your B12 level tested before supplementing for neuropathy.

Watch out

B12 is extremely safe even at high doses. The main risk is assuming it will help when deficiency isn't the underlying problem.

Pro tip

Methylcobalamin is the form used in the key neuropathy trial and is the active coenzyme form. Sublingual delivery bypasses potential absorption issues in the gut.

Evidence by outcome

Improve nerve signals in neuropathy Likely helps

d=0.09 Minimal effect 6 endpoints trust 66

Ease nerve pain symptoms Early data

d=0.43 Small effect 1 endpoints trust 38

Ease neuropathy symptoms Early data

d=0.35 Small effect 2 endpoints trust 38

Palmitoylethanolamide (PEA)

Early data

Very early · 37 Large effect

A promising pain-modulator with early but striking neuropathy results

600 mg daily for neuropathic pain. Some chronic pain trials used up to 1200 mg.

Pain reduction appeared within the first month in the diabetic neuropathy trial, with continued improvement through 8 weeks.

Full breakdown

How it works

PEA is a fatty acid compound your body produces naturally to dampen pain signaling and inflammation. It works through the endocannabinoid system, specifically activating a receptor called PPAR-alpha that dials down inflammatory processes in nerve tissue. Unlike CBD, PEA doesn't bind cannabinoid receptors directly but rather amplifies your body's own pain-braking system.¹⁰¹³

What the research says

One well-designed RCT of 70 people with diabetic neuropathic pain found that 600 mg PEA daily for 8 weeks produced large reductions in pain severity, stabbing sensations, and pins-and-needles symptoms, with secondary benefits for sleep and mood.¹⁰ That's a striking result for a single trial, but it is a single trial. A separate pilot study of 88 people with chemotherapy-induced neuropathy found no benefit at all.¹¹ A small crossover study in 14 healthy volunteers showed PEA improved pain thresholds and the body's own pain-suppression mechanisms.¹³ The general chronic pain meta-analysis is encouraging, showing continued pain reduction over 60 days.¹⁰ But for neuropathy specifically, this is still early-stage evidence.

Best for

People with diabetic neuropathic pain looking to add a well-tolerated supplement alongside conventional treatment. May be worth trying if ALA hasn't helped enough.

Watch out

Micronized or ultra-micronized formulations were used in all positive trials. Standard PEA powder may not absorb well enough to replicate the results.

Evidence by outcome

Improve nerve signals in neuropathy Not enough research

d=0.06 Minimal effect 6 endpoints trust 39

Ease nerve pain symptoms Early data

d=1.51 Large effect 2 endpoints trust 37

Ease diabetic nerve symptoms Early data

d=1.29 Large effect 1 endpoints trust 37

Ease neuropathy symptoms Early data

d=1.79 Large effect 3 endpoints trust 15

What doesn't work

Save your money on these

Acetyl-L-Carnitine Not enough research

Often recommended for neuropathy based on older trials, but the clinical evidence has not held up well in recent reviews. Most available research covers fertility outcomes, not nerve function. For neuropathy specifically, the data barely exists.

Evening Primrose Oil Not enough research

Frequently suggested based on the theory that gamma-linolenic acid supports nerve membrane health. In practice, the clinical trial evidence for neuropathy is nearly nonexistent. Evening primrose oil has solid data for breast pain and menopausal symptoms, but nerve pain is not among its strengths.

Vitamin B6 (Pyridoxine) Not enough research

Ironically, the B vitamin most associated with neuropathy is also the one that can cause it. Chronic intake above 100 mg daily is a well-documented cause of peripheral neuropathy. At supplemental doses it has almost no neuropathy treatment data, and taking too much can make things worse.

Synergistic stacks

Combinations that work better together

The Diabetic Neuropathy Foundation

Alpha-Lipoic Acid + Vitamin B12

ALA addresses oxidative nerve damage while B12 replenishes the building blocks for myelin repair, especially relevant if you take metformin.⁶⁸

ALA 600 mg on an empty stomach in the morning. B12 1000 mcg methylcobalamin with food. Both taken daily.

The Pain-Forward Stack

PEA + Alpha-Lipoic Acid

PEA targets the pain signaling side while ALA addresses the oxidative damage driving nerve deterioration. Different mechanisms with no known interaction.¹⁰³

PEA 600 mg with food. ALA 600 mg on an empty stomach. Both daily.

Buying guide

What to look for on the label

Form matters

•For alpha-lipoic acid, the R-form (R-ALA) is the biologically active enantiomer. Most clinical trials used racemic ALA (a 50/50 mix of R and S forms), so either works, but R-ALA may be effective at lower doses.
•For B12, methylcobalamin is the form studied for neuropathy. Cyanocobalamin (the cheaper form) converts to methylcobalamin in the body, but the conversion may be less efficient in people with absorption issues.
•For PEA, micronized or ultra-micronized formulations are essential. Standard PEA powder has poor bioavailability. Look for products that specify particle size reduction on the label.

Red flags

•Neuropathy supplement blends that combine tiny doses of everything rather than clinical doses of one or two ingredients. A product with 50 mg of ALA and 100 mcg of B12 is not replicating any clinical trial.
•Products making claims about 'nerve repair' or 'nerve regeneration.' No oral supplement has been shown to regrow damaged nerves in humans.
•B6 doses above 50 mg in a neuropathy product. High-dose B6 causes the very condition you're trying to treat.

Quality markers

•Third-party testing (USP, NSF, or ConsumerLab verification) is especially important for ALA, where purity varies across manufacturers.
•Products that specify the exact form and dose matching clinical trial protocols (e.g., 600 mg racemic ALA, 1000 mcg methylcobalamin).

The bottom line

Neuropathy supplement research is thinner than most people expect. Alpha-lipoic acid has the deepest evidence base but still lacks a definitive long-term verdict from independent reviewers. B12 supplementation is straightforward and well-supported if you're deficient, especially on metformin. PEA is worth watching but needs larger trials before anyone can call it reliable.

The honest takeaway: supplements for neuropathy are best understood as adjuncts, not replacements for blood sugar management, physical therapy, or prescription medications when symptoms are severe. Start with getting your B12 and blood sugar checked. If you want to try ALA or PEA on top of that, the safety profiles are reassuring and the cost is low, but calibrate your expectations accordingly.

Frequently asked

Common questions

Does alpha-lipoic acid actually work for neuropathy?

It depends what you mean by 'work.' Multiple trials show it improves symptom scores like burning, tingling, and numbness in diabetic neuropathy over 3 to 5 months.³ But a 2024 Cochrane review of the longest trials concluded the benefits at six months were 'probably little or no effect.'⁵ The honest answer is that it likely helps with symptom comfort more than it reverses nerve damage, and 600 mg daily appears to be the sweet spot.

Should I take B12 for neuropathy even if I'm not deficient?

Probably not. The strongest neuropathy trial specifically enrolled people with low B12 levels from long-term metformin use.⁸ A separate trial in older adults with moderate B12 deficiency (but not diabetes) showed no nerve benefit from supplementation.⁹ Get your B12 tested first. If it's normal, B12 supplementation is unlikely to help your neuropathy.

What about B-complex supplements for nerve health?

B-complex products are popular but the evidence doesn't support them as a class for neuropathy. B12 helps if you're deficient. B1 (thiamine) deficiency can cause neuropathy but is rare outside of alcoholism. B6 is actually dangerous for nerves at high doses. Taking a B-complex 'just in case' is low-risk at normal doses but unlikely to improve neuropathy symptoms unless you have a specific deficiency.

Is PEA safe to take with prescription pain medications?

Clinical trials found PEA to be very well tolerated, with side effects similar to placebo.¹⁰¹¹ Animal studies suggest PEA may enhance the effects of some analgesics like acetaminophen and tramadol, which could theoretically be beneficial but also means you should tell your doctor if you're combining them. No serious drug interactions have been reported in human trials.

How long should I try a supplement before deciding it's not working?

For ALA, give it at least 3 months. The benefits in trials appeared gradually, and the longest trial ran 4 years.⁶ For B12, blood levels normalize quickly but nerve improvements can take 6 to 12 months.⁸ For PEA, pain improvements showed up within 4 to 8 weeks in the available trials.¹⁰ If you see no change after these timeframes, the supplement probably isn't your answer.

Want personalized peripheral neuropathy recommendations?

The Suplmnt app checks doses, flags interactions, and tracks what actually works for you.

Sources

Generated April 4, 2026